修改的5项脆弱性指数是否与口腔状细胞癌的存活率相关?
Marta Chmielecka1, Rhona Hurley1,2,3,4, Mohd Afid Mohd Slim5
1School of Medicine, Dentistry and Nursing, University of Glasgow, Glasgow, UK.
Head & neck
|August 9, 2025
概括
虚弱显著影响口腔状细胞癌 (OPSCC) 的存活率. 然而,在多变量分析中,修改后的5项脆弱性指数 (mFI-5) 并不是一个重要的预测指标,HPV和绩效状态是更强的指标.
科学领域:
- 在瘤学瘤学.
- 老年病的医生 老年病的医生
- 公共卫生 公共卫生
背景情况:
- 口腔状细胞癌 (OPSCC) 是一种常见的头癌.
- 众所周知,脆弱会对头癌的存活率产生负面影响.
- 脆弱性对OPSCC生存率的影响仍在调查中.
研究的目的:
- 调查通过修改的5项脆弱指数 (mFI-5) 测量的脆弱性与OPSCC患者的生存结果之间的关联.
- 探索与脆弱性水平相关的整体生存率 (OS) 和疾病特异性生存率 (DSS).
主要方法:
- 在西苏格兰2012年至2020年间诊断的1001名OPSCC患者的回顾性队列研究.
- 利用修改后的5项脆弱性指数 (mFI-5) 来评估患者的脆弱性.
- 进行了单变量和多变量生存分析.
主要成果:
- 与"不脆弱" (82个月) 相比",中度脆弱" (39个月) 和"严重脆弱" (11个月) 组的中位寿命显著更短.
- 在"严重脆弱" (16个月) 和"中度脆弱" (66个月) 中,DSS的时间较短.
- 在调整HPV和绩效状态 (PS) 后,在多变量分析中,脆弱性不是OS或DSS的显著预测因素.
结论:
- 根据mFI-5的评估,虚弱度的增加与OPSCC患者的生存率显著下降有关.
- 性能状态 (PS) 和HPV状态是OPSCC中OS和DSS的更强大的预测因素,而不是脆弱性.
- 进一步的研究可能会完善脆弱性评估在OPSCC预后中的作用.
更多相关视频
相关概念视频
01:21Cancer Survival Analysis
455
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
455
01:20Comparing the Survival Analysis of Two or More Groups
286
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
286
01:15Assumptions of Survival Analysis
197
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
197
01:09Truncation in Survival Analysis
304
Truncation in survival analysis refers to the exclusion of individuals or events from the dataset based on specific criteria related to the time of the event. This exclusion can happen in two primary forms: left truncation and right truncation.
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are...
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are...
304
01:24Kaplan-Meier Approach
264
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
264
02:07Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K